Immediate Impact
1 by Nobel laureates 16 from Science/Nature 62 standout
Citing Papers
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
Deciphering breast cancer: from biology to the clinic
2023 Standout
Works of David Huntsman being referenced
Can we define tumors that will respond to PARP inhibitors? A phase II correlative study of olaparib in advanced serous ovarian cancer and triple-negative breast cancer.
2010
Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Huntsman | 558 | 652 | 359 | 27 | 1.3k | |
| Nikita Makretsov | 671 | 578 | 370 | 18 | 1.4k | |
| G. Goovaerts | 554 | 575 | 416 | 38 | 1.3k | |
| E. Kumpulainen | 479 | 664 | 268 | 41 | 1.5k | |
| Elvira Benini | 737 | 1013 | 541 | 30 | 1.5k | |
| Ann‐Marie Baker | 743 | 610 | 399 | 41 | 1.6k | |
| Pierre Rudolph | 614 | 601 | 332 | 42 | 1.4k | |
| Paul J. van Diest | 822 | 538 | 447 | 36 | 1.6k | |
| McCarty Ks | 524 | 648 | 429 | 16 | 1.5k | |
| Brian P. Adley | 712 | 342 | 306 | 30 | 1.4k | |
| Bonnie L. King | 460 | 597 | 357 | 35 | 1.2k |
All Works
Loading papers...